000 01376 a2200397 4500
005 20250515184952.0
264 0 _c20091116
008 200911s 0 0 eng d
022 _a1365-2710
024 7 _a10.1111/j.1365-2710.2009.01067.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSmall, D S
245 0 0 _aPharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease.
_h[electronic resource]
260 _bJournal of clinical pharmacy and therapeutics
_cOct 2009
300 _a575-83 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiver Diseases
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPiperazines
_xadverse effects
650 0 4 _aPlatelet Aggregation Inhibitors
_xpharmacokinetics
650 0 4 _aPrasugrel Hydrochloride
650 0 4 _aThiophenes
_xadverse effects
700 1 _aFarid, N A
700 1 _aLi, Y G
700 1 _aErnest, C S
700 1 _aWinters, K J
700 1 _aSalazar, D E
700 1 _aPayne, C D
773 0 _tJournal of clinical pharmacy and therapeutics
_gvol. 34
_gno. 5
_gp. 575-83
856 4 0 _uhttps://doi.org/10.1111/j.1365-2710.2009.01067.x
_zAvailable from publisher's website
999 _c19142432
_d19142432